World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
56
Citations
15960
World Ranking
3677
National Ranking
1694

Sharon E. Frey publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Sharon E. Frey sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 150 publications — 16th percentile

16% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Sharon E. Frey D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Sharon E. Frey sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 56 D-Index — 26th percentile

26% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Sharon E. Frey is affiliated with Saint Louis University in the United States and has contributed extensively to the field of Medicine, with a primary focus on Infectious Diseases. Their research outputs encompass a range of subfields including Infectious Diseases, Epidemiology, Immunology, Molecular Biology, and Virology.

The scientist has explored multiple research topics, with a notable emphasis on viral infections and outbreaks. Main topics include:

  • Influenza Virus Research Studies
  • SARS-CoV-2 and COVID-19 Research
  • Respiratory viral infections research
  • Viral Infections and Outbreaks Research
  • COVID-19 Clinical Research Studies
  • Poxvirus research and outbreaks
  • Bacillus and Francisella bacterial research

Sharon E. Frey's publication record features several recent papers that address vaccination and infectious disease prevention strategies. Selected papers include:

  • Universal Hepatitis B Vaccination in Adults Aged 19-59 Years: Updated Recommendations of the Advisory Committee on Immunization Practices - United States, 2022, published in MMWR Morbidity and Mortality Weekly Report
  • Use of a Modified Preexposure Prophylaxis Vaccination Schedule to Prevent Human Rabies: Recommendations of the Advisory Committee on Immunization Practices - United States, 2022, published in MMWR Morbidity and Mortality Weekly Report
  • Use of Ebola Vaccine: Recommendations of the Advisory Committee on Immunization Practices, United States, 2020, published in MMWR Recommendations and Reports
  • Comparison of bivalent and monovalent SARS-CoV-2 variant vaccines: the phase 2 randomized open-label COVAIL trial, 2023, published in Nature Medicine
  • Variability in the Management of Adults With Pulmonary Nontuberculous Mycobacterial Disease, 2020, published in Clinical Infectious Diseases

The scientist frequently collaborates with other researchers in the field. Notable coauthors include:

  • Robert L. Atmar
  • Nadine Rouphael
  • Lisa A. Jackson
  • Emmanuel B. Walter
  • Getahun Abate

Publication venues where Sharon E. Frey's work appears reflect a strong presence in infectious disease and immunization research. Key venues include:

  • Clinical Infectious Diseases
  • Vaccine
  • bioRxiv (Cold Spring Harbor Laboratory)
  • The Journal of Infectious Diseases
  • MMWR Morbidity and Mortality Weekly Report

Best Publications

  • Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine.

    Lindsey R. Baden;Hana M El Sahly;Brandon J Essink;Karen Kotloff

  • Clinical responses to undiluted and diluted smallpox vaccine.

    Sharon E. Frey;Robert B. Couch;Carol O. Tacket;John J. Treanor

  • Adjuvanted Intranasal Norwalk Virus-Like Particle Vaccine Elicits Antibodies and Antibody-Secreting Cells That Express Homing Receptors for Mucosal and Peripheral Lymphoid Tissues

    Samer S. El-Kamary;Marcela F. Pasetti;Paul M. Mendelman;Sharon E. Frey

  • Safety and Immunogenicity of HCV E1E2 Vaccine Adjuvanted with MF59 Administered to Healthy Adults

    Sharon E. Frey;Michael Houghton;Stephen Coates;Sergio Abrignani

  • Dose-related effects of smallpox vaccine.

    Sharon E. Frey;Frances K. Newman;John Cruz;W. Brian Shelton

  • A hepatitis C virus (HCV) vaccine comprising envelope glycoproteins gpE1/gpE2 derived from a single isolate elicits broad cross-genotype neutralizing antibodies in humans.

    John Lok Man Law;Chao Chen;Jason Wong;Darren Hockman

  • Safety and immunogenicity of a canarypox-vectored human immunodeficiency virus Type 1 vaccine with or without gp120: a phase 2 study in higher- and lower-risk volunteers.

    Robert B. Belshe;Cladd Stevens;Geoffrey J. Gorse;Susan Buchbinder

  • Phase 1 Safety and Immunogenicity Testing of DNA and Recombinant Modified Vaccinia Ankara Vaccines Expressing HIV-1 Virus-like Particles

    Paul A. Goepfert;Marnie L. Elizaga;Alicia Sato;Li Qin

  • AS03-adjuvanted versus non-adjuvanted inactivated trivalent influenza vaccine against seasonal influenza in elderly people: a phase 3 randomised trial

    Janet E McElhaney;Jiri Beran;Jeanne-Marie Devaster;Meral Esen

  • Clinical Efficacy of Cell Culture—Derived and Egg-Derived Inactivated Subunit Influenza Vaccines in Healthy Adults

    Sharon Frey;Timo Vesikari;Agnieszka Szymczakiewicz-Multanowska;Maria Lattanzi

  • Comparison of the safety and immunogenicity of an MF59®-adjuvanted with a non-adjuvanted seasonal influenza vaccine in elderly subjects.

    Sharon E. Frey;Mari Rose Aplasca-De Los Reyes;Humberto Reynales;Nancy Nazaire Bermal

  • A Novel Intramuscular Bivalent Norovirus Virus-Like Particle Vaccine Candidate—Reactogenicity, Safety, and Immunogenicity in a Phase 1 Trial in Healthy Adults

    John J. Treanor;Robert L. Atmar;Sharon E. Frey;Robert Gormley

  • Comparison of the safety, tolerability, and immunogenicity of a MF59-adjuvanted influenza vaccine and a non-adjuvanted influenza vaccine in non-elderly adults.

    Sharon Frey;Gregory Poland;Sandra Percell;Audino Podda

  • Comparative immunogenicity of trivalent influenza vaccine administered by intradermal or intramuscular route in healthy adults.

    Robert B. Belshe;Frances K. Newman;Ken Wilkins;Irene L. Graham

  • Phase 2 Study of an HIV-1 Canarypox Vaccine (vCP1452) Alone and in Combination With rgp120: Negative Results Fail to Trigger a Phase 3 Correlates Trial

    Nina D. Russell;Nina D. Russell;Nina D. Russell;Barney S. Graham;Michael C. Keefer;M. Juliana McElrath;M. Juliana McElrath

  • Response to Smallpox Vaccine in Persons Immunized in the Distant Past

    Sharon E. Frey;Frances K. Newman;Lihan Yan;Robert B. Belshe

  • Clinical and Immunologic Responses to Multiple Doses of IMVAMUNE® (Modified Vaccinia Ankara) Followed by Dryvax® Challenge

    Sharon E. Frey;Frances K. Newman;Jeffrey S. Kennedy;Vera Sobek

  • Glycosylations in the Globular Head of the Hemagglutinin Protein Modulate the Virulence and Antigenic Properties of the H1N1 Influenza Viruses

    Rafael A. Medina;Rafael A. Medina;Silke Stertz;Silke Stertz;Balaji Manicassamy;Balaji Manicassamy;Petra Zimmermann

  • Effect of varying doses of a monovalent H7N9 influenza vaccine with and without AS03 and MF59 adjuvants on immune response a randomized clinical trial

    Lisa A. Jackson;James D. Campbell;Sharon E. Frey;Kathryn M. Edwards

  • Effects of antigen dose and immunization regimens on antibody responses to a cytomegalovirus glycoprotein B subunit vaccine.

    Sharon E. Frey;Christopher Harrison;Robert F. Pass;Ellen Yang

Frequent Co-Authors

Robert B. Belshe
Robert B. Belshe Saint Louis University
Mark J. Mulligan
Mark J. Mulligan New York University
Lisa A. Jackson
Lisa A. Jackson Kaiser Permanente
Kathryn M. Edwards
Kathryn M. Edwards Vanderbilt University Medical Center
Robert L. Atmar
Robert L. Atmar Baylor College of Medicine
Wendy A. Keitel
Wendy A. Keitel Baylor College of Medicine
Michael C. Keefer
Michael C. Keefer University of Rochester
Emmanuel B. Walter
Emmanuel B. Walter Duke University
David I. Bernstein
David I. Bernstein University of Cincinnati
Paul Spearman
Paul Spearman Cincinnati Children's Hospital Medical Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in immunology, exploring related healthcare degrees can open doors to diverse career opportunities. Many students start their journey with foundational programs, such as the easiest lpn programs to get into, which offer flexible admission criteria and hands-on training. This pathway often leads to advanced nursing roles.

Advancing further, aspiring advanced practice nurses can consider nurse practitioner programs with easy admission. These programs provide a streamlined entry point to specialized nursing fields, including those focused on immunological health and patient care.

Specialization is key for those seeking mental health expertise. Online options such as online pmhnp programs with clinical placement combine theoretical learning with valuable hands-on experience, helping students bridge the gap between education and practice in psychiatric nursing.

Cost is often a consideration when selecting a program. Students can find budget-friendly options through resources like the cheapest online pmhnp certificate programs. These programs provide quality education and certification opportunities without a heavy financial burden, making career advancement more accessible.

Best Scientists Citing Sharon E. Frey

Trending Scientists

Recently Published Articles